Chinese SFDA Reorganization Creates “Good Opportunity” For Supplement Firms – NPA
This article was originally published in PharmAsia News
Executive Summary
The reorganization of China's State FDA should create a "really good opportunity" for the dietary supplement industry, says Jeff Crowther, director of the Natural Products Association's office in China